RFA - Richard Olney, MD, Clinician-Scientist Development Three-Year Award
April 23, 2012
The American Academy of Neurology (AAN) Foundation and the ALS Association are pleased to announce a three-year Richard Olney, MD, Clinician-Scientist Development Award to support a clinician-scientist’s research related to amyotrophic lateral sclerosis. The award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies. The three-year award will consist of an annual salary of $75,000, plus $5,000 in educational expenses, per year. Only direct costs will be funded by this award.
Application Deadline: October 1, 2012
Click here for application details.
Related News
Phase III Dex Trial Discussion
February 7, 2013
Reprogramming Neurons Shows They Can Take on New Identities
January 29, 2013
Biogen Announces It Will Discontinue Development of Dexpramipexole Based on Phase 3 Trial Results
January 3, 2013





